Does low-dose prolonged steroid therapy affect the natural history of chronic hepatitis C?

about

Role of LncRNA-AF085935, IL-10 and IL-17 in Rheumatoid Arthritis Patients With Chronic Hepatitis C.

P2860

Q37737191-7E94061A-7418-4C48-B080-1AFB79FA0F57

P2860

Does low-dose prolonged steroid therapy affect the natural history of chronic hepatitis C?

Item

http://www.wikidata.org/entity/Q42239858

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Does low-dose prolonged steroi ...... istory of chronic hepatitis C?

@en

Does low-dose prolonged steroi ...... istory of chronic hepatitis C?

@nl

type

Item

label

Does low-dose prolonged steroi ...... istory of chronic hepatitis C?

@en

Does low-dose prolonged steroi ...... istory of chronic hepatitis C?

@nl

prefLabel

Does low-dose prolonged steroi ...... istory of chronic hepatitis C?

@en

Does low-dose prolonged steroi ...... istory of chronic hepatitis C?

@nl

P1476

Does low-dose prolonged steroi ...... istory of chronic hepatitis C?

@en

P2093

Ana Moreno Zamora

http://www.w3.org/2001/XMLSchema#string

Juan José Sánchez Ruano

http://www.w3.org/2001/XMLSchema#string

Rafael Bárcena Marugán

http://www.w3.org/2001/XMLSchema#string

Santos del Campo Terrón

http://www.w3.org/2001/XMLSchema#string

Tomás Artaza Varasa

http://www.w3.org/2001/XMLSchema#string

P2860

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

A "NEW" ANTIGEN IN LEUKEMIA SERA

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

Prednisone withdrawal followed by interferon alpha for treatment of chronic hepatitis C infection: results of a randomized controlled trial.

Fibrosis in patients with chronic hepatitis C: detection and significance.

Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.

Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group.

Non-invasive evaluation of liver fibrosis using transient elastography.

Glucocorticoids, lipocortins and the immune response.

P304

758-764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.23889

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marta Romero Gutiérrez

P577

2014-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24482317

http://www.w3.org/2001/XMLSchema#string

Does low-dose prolonged steroid therapy affect the natural history of chronic hepatitis C?

about

P2860

P2860

Does low-dose prolonged steroid therapy affect the natural history of chronic hepatitis C?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698